Nasdaq:AKTS – SPAC Feed

Nasdaq:AKTS
TEMP12345678

January 13, 2026

Aktis Oncology Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

BOSTON, Jan. 13, 2026 (GLOBE NEWSWIRE) — Aktis Oncology, Inc. (“Aktis”), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to…

By sf-admin